Torthaí cuardaigh - Sumimasa Nagai

  • 1 - 2 toradh as 2 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Flexible and Expedited Regulatory Review Processes for Innovative Medicines and Regenerative Medical Products in the US, the EU, and Japan

    Flexible and Expedited Regulatory Review Processes for Innovative Medicines and Regenerative Medical Products in the US, the EU, and Japan de réir Sumimasa Nagai

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies

    Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies de réir Gita Thanarajasingam, Lori M. Minasian, Frédéric Baron, Franco Cavalli, R. Angelo de Claro, Amylou C. Dueck, Tarec Christoffer El‐Galaly, Neil Everest, Jan Geißler, Christian Gisselbrecht, John G. Gribben, Mary M. Horowitz, S. Percy Ivy, Caron A. Jacobson, Armand Keating, Paul G. Kluetz, Aviva C. Krauss, Yok‐Lam Kwong, Richard F. Little, François-Xavier Mahon, Matthew J. Matasar, María‐Victoria Mateos, Kristen McCullough, Robert S. Miller, Mohamad Mohty, Philippe Moreau, Lindsay M. Morton, Sumimasa Nagai, Simon Rule, Jeff A. Sloan, Pieter Sonneveld, Carrie A. Thompson, Kyriaki Tzogani, Flora E. van Leeuwen, Galina Velikova, Diego Villa, John R. Wingard, Sophie Wintrich, John F. Seymour, Thomas M. Habermann

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: